Publisher: Bentham Science Publishers
E-ISSN: 2212-3938|6|3|199-206
ISSN: 1574-8847
Source: Current Clinical Pharmacology, Vol.6, Iss.3, 2011-08, pp. : 199-206
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma
Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. :
Emerging drugs for renal cell carcinoma
By Varella Leticia Rini Brian I
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
Emerging drugs for renal cell carcinoma
By Shaheen Philip E Bukowski Ronald M
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. :
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. :